Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque

Virchows Archiv

Volumn 453, Issue 1, 2008, Pages 69-77

  Bobryshev, Yuri V ^a   Killingsworth, Murray C ^b   Tran, Dihn ^c   Lord, Reginald ^c,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b SYDNEY SOUTH WEST AREA HEALTH SERVICE   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Arteries; Atherosclerosis; Chlamydia pneumoniae; Macrophages

Indexed keywords

FAT DROPLET; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CHLAMYDOPHILA PNEUMONIAE; ELECTRON MICROSCOPY; FEMALE; FOAM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGED; CAROTID ARTERY DISEASES; CAROTID STENOSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; FEMALE; FOAM CELLS; HUMANS; INCLUSION BODIES; MALE; MIDDLE AGED; VACUOLES;

EID: 48349137252     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-008-0629-2     Document Type: Article

References (63)

1. Belland RJ, Ouellette SP, Gieffers J, Byrne GI (2004) Chlamydia pneumoniae and atherosclerosis. Cell Microbiol 6:117-127
2. Bishara J, Pitlik S, Kazakov A, Sahar G, Haddad M, Vojdani A, Rosenberg S, Samra Z (2003) Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis. Eur J Clin Microbiol Infect Dis 22:300-302
3. Blessing E, Kuo CC, Lin TM, Campbell LA, Bea F, Chesebro B, Rosenfeld ME (2002) Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines. Circulation 105:1976-1982
4. Bobryshev YV (2005) Intracellular localization of oxidized low-density lipoproteins in atherosclerotic plaque cells revealed by electron microscopy combined with laser capture microdissection. J Histochem Cytochem 53:793-797
5. Bobryshev YV, Lord RSA (1996) Langhans cells of human arterial intima: uniform by stellate appearance but different by nature. Tissue Cell 28:177-194
6. Bobryshev YV, Lord RSA (1998) Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions. Cardiovasc Res 37:799-810
7. Bobryshev YV, Lord RSA, Watanabe T, Ikezawa T (1998) The cell adhesion molecule E-cadherin is widely expressed in human atherosclerotic lesions. Cardiovasc Res 40:191-205
8. Bobryshev YV, Cao W, Phoon MC, Tran D, Chow VT, Lord RS, Lu J (2004) Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesions. Atherosclerosis 173:185-195
9. Boman J, Gaydos CA (2000) Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis 181:S452-S454
10. Campbell LA, Kuo CC (2004) Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2:23-32
11. Campbell LA, Kuo CC, Grayston JT (1998) Chlamydia pneumoniae and cardiovascular disease. Emerg Infect Dis 4:571-579
12. Campbell LA, Perez Melgosa M, Hamilton DJ, Kuo CC, Grayston JT (1992) Detection of Chlamydia pneumoniae by polymerase chain reaction. J Clin Microbiol 30:434-439
13. Cao F, Castrillo A, Tontonoz P, Re F, Byrne GI (2007) Chlamydia pneumoniae-induced macrophage foam cell formation is mediated by Toll-like receptor 2. Infect Immun 75:753-759
14. Cirino F, Webley WC, West C, Croteau NL, Andrzejewski C Jr, Stuart ES (2006) Detection of Chlamydia in the peripheral blood cells of normal donors using in vitro culture, immunofluorescence microscopy and flow cytometry techniques. BMC Infect Dis 6:23
15. Da Costa CU, Wantia N, Kirschning CJ, Busch DH, Rodriguez N, Wagner H, Miethke T (2004) Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo. Eur J Immunol 34:2874-2884
16. de Villiers WJ, Smart EJ (1999) Macrophage scavenger receptors and foam cell formation. J Leukoc Biol 66:740-746
17. Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo CC, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR (2001) Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33:492-503
18. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ (2002) Expression of Toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105:1158-1161
19. Fryer RH, Schwobe EP, Woods ML, Rodgers GM (1997) Chlamydia species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med 45:168-174
20. Gaydos CA, Summersgill JT, Sahney NN, Ramirez JA, Quinn TC (1996) Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells. Infect Immun 64:1614-1620
21. Gieffers J, Füllgraf H, Jahn J, Klinger M, Dalhoff K, Katus HA, Solbach W, Maass M (2001) Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment. Circulation 103:351-356
22. Glass CK, Witztum JL (2001) Atherosclerosis. The road ahead. Cell 104:503-516
23. Godzik KL, O'Brien ER, Wang SK, Kuo CC (1995) In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae. J Clin Microbiol 33:2411-2414
24. Grant K, Jerome WG (2002) Laser capture microdissection as an aid to ultrastructural analysis. Microsc Microanal 8:170-175
25. Heinemann M, Susa M, Simnacher U, Marre R, Essig A (1996) Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 64:4872-4875
26. Hortovanyi E, Illyes G, Glasz T, Kadar A (2002) Chlamydia pneumoniae in different coronary artery segments in the young. Pathol Res Pract 198:19-23
27. Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580
28. Jackson LA, Campbell LA, Kuo CC, Rodriguez DI, Lee A, Grayston JT (1997) Isolation of Chlamydia pneumoniae from carotid endarterectomy specimen. J Infect Dis 176:292-295
29. Kalayoglu MV, Byrne GI (1998) A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect Immun 66:5067-5072
30. Kalayoglu MV, Byrne GI (1998) Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 177:725-729
31. Kalayoglu MV, Libby P, Byrne GI (2002) Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. JAMA 288:2724-2731
32. Kalayoglu MV, Hoerneman B, LaVerda D, Morrison SG, Morrison RP, Byrne GI (1999) Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae. J Infect Dis 180:780-790
33. Kalayoglu MV, Indrawati, Morrison RP, Morrison SG, Yuan Y, Byrne GI (2000) Chlamydial virulence determinants in atherogenesis: the role of chlamydial lipopolysaccharide and heat shock protein 60 in macrophage- lipoprotein interactions. J Infect Dis 181(Suppl 3):S483-S489
34. Keita M, Magy L, Richard L, Piaser M, Vallat JM (2002) LR white post-embedding colloidal gold method to immunostain MBP, P0, NF and S100 in glutaraldehyde-fixed peripheral nerve tissue. J Peripher Nerv Syst 7:128-133
35. Krüll M, Maass M, Suttorp N, Rupp J (2005) Chlamydophila pneumoniae. Mechanisms of target cell infection and activation. Thromb Haemost 94:319-326
36. Kutlin A, Flegg C, Stenzel D, Reznik T, Roblin PM, Mathews S, Timms P, Hammerschlag MR (2001) Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J Clin Microbiol 39:3721-3723
37. Kuo CC, Gown AM, Benditt EP, Grayston JT (1993) Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain. Arterioscler Thromb 13:1501-1504
38. Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT (1993) Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 167:841-849
39. Lang PD, Insull W Jr (1970) Lipid droplets in atherosclerotic fatty streaks of human aorta. J Clin Invest 49:1479-1488
40. Lin TM, Campbell LA, Rosenfeld ME, Kuo CC (2000) Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae. J Infect Dis 181:1096-1100
41. Liu L, Hu H, Ji H, Murdin AD, Pierce GN, Zhong G (2000) Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem 215:123-128
42. Loehe F, Bittmann I, Weilbach C, Lauterjung L, Schildberg FW, Heiss MM (2002) Chlamydia pneumoniae in atherosclerotic lesions of patients undergoing vascular surgery. Ann Vasc Surg 16:467-73
43. Lundberg B (1985) Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis 56:93-110
44. Lusis AJ (2000) Atherosclerosis. Nature 407:233-241
45. Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC (1999) Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 180:238-241
46. Moazed TC, Kuo CC, Grayston JT, Campbell LA (1998) Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J Infect Dis 177:1322-1325
47. Mussa FF, Chai H, Wang X, Yao Q, Lumsden AB, Chen C (2006) Chlamydia pneumoniae and vascular disease: an update. J Vasc Surg 43:1301-1307
48. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, Van der Meer JW, Dinarello CA (2000) Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells. Eur J Immunol 30:541-549
49. Ong GM, Coyle PV, Barros D'Sa AA, McCluggage WG, Duprex WP, O'Neill HJ, Wyatt DE, Bamford KB, O'Loughlin B, McCaughey C (2001) Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody. BMC Infect Dis 1:12
50. Peters J, Hess S, Endlich K, Thalmann J, Holzberg D, Kracht M, Schaefer M, Bartling G, Klos A (2005) Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection. Cell Microbiol 7:1099-1108
51. Prager M, Türel Z, Speidl WS, Zorn G, Kaun C, Niessner A, Heinze G, Huk I, Maurer G, Huber K, Wojta J (2002) Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals. Stroke 33:2756-2761
52. Prebeck S, Kirschning C, Dürr S, da Costa C, Donath B, Brand K, Redecke V, Wagner H, Miethke T (2001) Predominant role of Toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells. J Immunol 167:3316-3323
53. Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, Bertoloni G, Lauro FM, Zambello R, Bonoldi E (2001) Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 158:73-79
54. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340:115-126
55. Rupp J, Koch M, van Zandbergen G, Solbach W, Brandt E, Maass M (2005) Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model. FEMS Microbiol Lett 242:203-208
56. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Mäkelä PH, Huttunen JK, Valtonen V (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2:983-986
57. Simmons SR, Sims PA, Albrecht RM (1997) Alpha IIb beta 3 redistribution triggered by receptor cross-linking. Arterioscler Thromb Vasc Biol 17:3311-3320
58. Vink A, Poppen M, Schoneveld AH, Roholl PJ, de Kleijn DP, Borst C, Pasterkamp G (2001) Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual. Circulation 103:1613-1617
59. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL, Schulhoff N, Shani J, Frankel R, Penney K, Quinn TC, Hammerschlag MR, Schachter J (1996) Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis 173:957-962
60. Wolf K, Fischer E, Hackstadt T (2000) Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells. Infect Immun 68:2379-12385
61. Wolf K, Fischer E, Hackstadt T (2005) Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells. Infect Immun 73:4560-4570
62. Yamashita K, Ouchi K, Shirai M, Gondo T, Nakazawa T, Ito H (1998) Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29:773-778
63. Yaraei K, Campbell LA, Zhu X, Liles WC, Kuo CC, Rosenfeld ME (2005) Effect of Chlamydia pneumoniae on cellular ATP content in mouse macrophages: role of Toll-like receptor 2. Infect Immun 73:4323-4326